Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors

Biochemical Pharmacology

Volumn 75, Issue 5, 2008, Pages 1198-1208

  Varani, Katia ^a   Surprenant, Annmarie ^b   Vincenzi, Fabrizio ^a   Tosi, Alice ^a   Gessi, Stefania ^a   Merighi, Stefania ^a   Borea, Pier Andrea ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

3H meATP binding; Agonist antagonist discrimination; Binding thermodynamics; Enthalpy entropy compensation; HEK 293 cells; P2X1 and P2X3 purinergic receptors

Indexed keywords

PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X3 RECEPTOR;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENTHALPY; ENTROPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERATURE SENSITIVITY; THERMODYNAMICS;

BINDING, COMPETITIVE; CELL LINE; HUMANS; KINETICS; RECEPTORS, PURINERGIC P2; THERMODYNAMICS;

EID: 38949112136     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.10.034     Document Type: Article

References (40)

1. North R.A. Molecular physiology of P2X receptors. Physiol Rev 82 (2002) 1013-1067
2. North R.A., and Surprenatant A. Pharmacology of cloned P2X receptors. Ann Rev Pharmacol Toxicol 40 (2000) 563-580
3. Burnstock G. Purinergic signalling. Br J Pharmacol 147 (2006) 172-181
4. Sawynok J. Adenosine and ATP receptors. Handb Exp Pharmacol 177 (2007) 309-328
5. Khakh B.S., and North R.A. P2X receptors as cell surface ATP sensors in health and disease. Nature 442 (2006) 527-532
6. Burnstock G., and Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240 (2004) 31-34
7. Kennedy C. P2X receptors: targets for novel analgesics?. Neuroscientist 11 (2005) 345-356
8. 3 homomeric and heteromeric channels to acute and chronic pain. Expert Opin Ther Targets 7 (2003) 513-522
9. In: Abbracchio M.P., and Williams M. (Eds). Handbook of experimental pharmacology: purinergic and pirimidinergic signaling vol. 151 (I and II) (2001), Springer, Berlin
10. King BF, North RA, editors. Purine and the autonomic nervous system: from controversy to clinic. J Auton Nerv Syst 2000;81:1-299.
11. Jacobson K.A., Jarvis M.F., and Williams M. Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 45 (2002) 4057-4093
12. 3 receptors. J PET 310 (2004) 407-416
13. 2/3 receptors by 2′,3′-O-(2,4,6-trinitrophenyl)adenosine 5′-triphosphate (TNP-ATP). Mol Pharmacol 58 (2000) 1502-1510
14. 3H]αβmeATP in rat urinary bladder membranes. Br J Pharmacol 101 (1990) 291-296
15. 3H]αβmeATP may label an endothelial-derived cell line 5′-nucleotidase with high affinity. Br J Pharmacol 115 (1995) 767-774
16. 33P]ATP. Br J Pharmacol 117 (1996) 1254-1260
17. 3H]αβmeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations. Br J Pharmacol 121 (1997) 913-922
18. Borea P.A., Dalpiaz A., Varani K., Gilli P., and Gilli G. Can thermodynamic measurement of receptor binding yield information on drug affinity and efficacy?. Biochem Pharmacol 60 (2000) 1549-1556
19. 2A adenosine receptors. Life Sci 59 (1996) 1373-1388
20. Borea P.A., Varani K., Gessi S., Gilli P., and Gilli G. Binding thermodynamics at the human neuronal nicotine receptor. Biochem Pharmacol 55 (1998) 1189-1197
21. 3 adenosine receptors. Biochem Pharmacol 63 (2002) 157-161
22. Gilli P., Gilli G., Borea P.A., Varani K., Scatturin A., and Dalpiaz A. Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors. J Med Chem 48 (2005) 2026-2035
23. Maksai G. Thermodynamics of ionotropic GABAA, Glycine and 5-HT3 type serotonin receptor interactions. In: Raffa R.B. (Ed). Drug receptor thermodynamics: introduction and applications (2001), Wiley & Sons, New York 359-376
24. Gessi S., Dalpiaz A., Varani K., and Borea P.A. Temperature dependence and GABA modulation of βcarboline binding to rat cerebellum benzodiazepine receptors. Life Sci (1999) 185-192
25. Borea P.A., Varani K., Gessi S., Merighi S., Dalpiaz A., Gilli P., et al. Receptor binding thermodynamics at the neuronal nicotinic receptors. Curr Top in Med Chem 4 (2004) 361-368
26. Stoop R., Surprenant A., and North R.A. Different sensitivities to pH of ATP induced currents at four cloned P2X receptors. J Neurophysiol 78 (1997) 1837-1840
27. 2x-purinoceptors in the heart: actions of ATP and UTP. Life Sci 60 17 (1997) 1419-1430
28. 2A receptor ligands. Biochem Pharmacol 49 (1995) 461-469
29. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72 (1976) 248
30. Munson P.J., and Rodbard D. Ligand: a versatile computerized approach for the characterization of ligand binding systems. Anal Biochem 107 (1980) 220-239
31. Gilli P., Ferretti V., Gilli G., and Borea P.A. Enthalpy-entropy compensation in drug-receptor Binding. J Phys Chem 98 (1994) 1515-1518
32. Grunwald E., and Steel C. Solvent reorganization and thermodynamic enthalpy-entropy compensation. J Am Chem Soc 117 (1995) 5687-5692
33. Raffa R.B. In: Raffa R.B. (Ed). Drug-receptor thermodynamics: introduction and applications (2001), Wiley & Sons, New York 221-416
34. Lorenzen A., Guerra L., Campi F., Lang H., Schwabe U., and Borea P.A. Thermodynamically distinct high and low affinity states of the A(1) adenosine receptor induced by G protein coupling and guanine nucleotide ligation states of G proteins. Br J Pharmacol 130 3 (2000) 595-604
35. Tomlinson E., and Steel C. Solvent reorganization and thermodynamic enthalpy-entropy compensation. J Am Chem Soc 13 (1983) 115-144
36. 35S)-ADPβS as radioligand for ionotropic and metabotropic P2 receptor binding. Drug Dev Res 48 (1999) 84-93
37. Lambrecht G. Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn Schmiedebergs Arch Pharmacol 362 (2000) 340-350
38. 3H]alpha,beta-methylene ATP binding in rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol 350 (1994) 113-122
39. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87 (2007) 659-797
40. 2/3 receptors. Mol Pharmacol 53 (1998) 969-973